Welcome to Current Immunology, Today is
IFN-α/anti-PD-L1 fusion protein activates tumor specific CD8(+) T lymphocyte responses for anti-tumor efficacy
YIN Zhi-wen, HOU Ji-yan, HAN Ping, et al
Current Immunology . 2019, (1): 1 -7 .